机译:Prediagnostic循环性激素与具有前列腺癌的男性的死亡率无关
Department of Urology Massachusetts General Hospital Boston MA United States;
Department of Epidemiology Harvard School of Public Health Boston MA 02115 United States;
Department of Epidemiology Harvard School of Public Health Boston MA 02115 United States;
Department of Epidemiology Johns Hopkins Bloomberg School of Public Health Baltimore MD United;
Department of Pathology University of Illinois at Chicago Chicago IL United States;
Department of Medicine Brigham and Women's Hospital Harvard Medical School Boston MA United;
Department of Epidemiology Harvard School of Public Health Boston MA 02115 United States;
Department of Epidemiology Harvard School of Public Health Boston MA 02115 United States;
Department of Epidemiology Harvard School of Public Health Boston MA 02115 United States;
Androgens; Mortality; Prostate cancer; Sex hormones; Testosterone;
机译:男性前列腺癌的诊断前循环性激素与死亡率无关
机译:循环预测白细胞介素-6和C反应蛋白和前列腺癌发病率和死亡率。
机译:全基因组重要遗传变异与胰岛素样生长因子1,性激素和结合蛋白的循环浓度之间的相互作用与美国国家癌症研究所乳腺癌和前列腺癌研究小组的前列腺癌风险相关
机译:乳腺癌和前列腺癌中性激素结合球蛋白(SHBG)表达的免疫组织化学和原位检测:激素调节的影响
机译:脂联素与心血管动脉粥样硬化和死亡率的关联中的性别差异:内源性激素的作用。
机译:pediagnostic循环性激素与具有前列腺癌的男性的死亡率无关
机译:Prediagnostic循环抗Müllerian激素浓度与前列腺癌风险无关